Author:
Shafrin Jason,Schwartz Taylor T.,Okoro Tony,Romley John A.
Subject
Public Health, Environmental and Occupational Health,Health Policy
Reference37 articles.
1. How cancer patients value hope and the implications for cost-effectiveness assessments of high-cost cancer therapies;Lakdawalla;Health Aff (Millwood),2012
2. A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS);Cherny;Ann Oncol,2015
3. Institute for Clinical and Economic Review;Evaluating the Value of New Drugs and Devices,2015
4. Memorial Sloan Kettering Cancer Center. Methods 2015. Available from: http://www.drugabacus.org/methods/. [Accessed December 4, 2015].
5. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN Guidelines) with NCCN Evidence Blocks. 2015. Available from: http://www.nccn.org/evidenceblocks/. [Accessed December 4, 2015].
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献